Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Ceftazidime-avibactam is a novel cephalosporin–beta-lactamase inhibitor combination that is active against many carbapenem-resistant Enterobacteriaceae (CRE). We describe a retrospective chart review for 60 patients who received ceftazidime-avibactam for a CRE infection. In-hospital mortality was 32...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antimicrob Agents Chemother
Huvudupphovsmän: King, Madeline, Heil, Emily, Kuriakose, Safia, Bias, Tiffany, Huang, Vanthida, El-Beyrouty, Claudine, McCoy, Dorothy, Hiles, Jon, Richards, Lynette, Gardner, Julianne, Harrington, Nicole, Biason, Kenneth, Gallagher, Jason C.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2017
Ämnen:
Clinical Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487633/
https://ncbi.nlm.nih.gov/pubmed/28483952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00449-17
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk